This brand name is authorized in Nigeria.
The drug CLOGNIL contains one active pharmaceutical ingredient (API):
1
|
UNII
08I79HTP27 - CLOPIDOGREL BISULFATE
|
|
Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100826 | Tablet | Clognil Tablet TAB 75 mg 3 X 10 | 41 NF-PP-90173 Clognil Tablet Clopidogrel Tablet USP 75Mg Clopidogrel Bisulfate equivalent to 75 mg of Clopidogrel, Microcrystalline Cellulose (Avicel PH 101), Pregelatinized Starch (Starch-1500), Polyvinyl Pyrrolidone (Povidone K-30), Magnesium Stearate, Colloidal Silicon Dioxide (Aerosil 200), Hydroxy Propyl Methyl Cellulose (15 cps), Titanium Dioxide, Castrol Oil, Methylene Chloride, Isopropyl Alcohol. A4-100826 Drugs Imported Products 310blisterpacks Prescription Only Medicine (POM) MIKCHEMA PHARMACEUTICALS & RESOURCES LTD, MODERN MARKET ROAD MAKURDI BENUE 9036101224 mikchemaglobal@gmail.com Orion Pharma Ltd., Orion House, 153-154, Tejgaon Industrial Area, Dhaka, Bangladesh | 30/04/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100826 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.